Humabs discovers the first antibody to neutralize both group 1 and group 2 influenza A viruses
Researchers at Humabs BioMed SA have discovered the first antibody to target all 16 hemagglutinin subtypes of influenza A, representing a promising treatment option for severe cases of flu. The novel monoclonal antibody, FI6, has been shown to protect mice and ferrets from infection by influenza A virus using multiple mechanisms.